Krensavage Asset Management, LLC Avanos Medical, Inc. Transaction History

Krensavage Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$31.89 - $47.34 $1.9 Million - $2.81 Million	-59,429 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$32.06 - $44.0 $1,635 - $2,244	51 Added 0.09%	59,429 $2.23 Million
Q2 2019 Aug 14, 2019	SELL	$37.68 - $46.52 $100,944 - $124,627	-2,679 Reduced 4.32%	59,378 $2.59 Million
Q1 2019 May 15, 2019	SELL	$39.84 - $51.04 $97,926 - $125,456	-2,458 Reduced 3.81%	62,057 $2.65 Million
Q4 2018 Feb 15, 2019	SELL	$41.16 - $66.67 $5,186 - $8,400	-126 Reduced 0.19%	64,515 $2.89 Million
Q4 2018 Feb 14, 2019	SELL	$41.16 - $66.67 $395,835 - $641,165	-9,617 Reduced 12.95%	64,641 $2.93 Million
Q3 2018 Nov 14, 2018	BUY	$55.13 - $72.65 $4.09 Million - $5.39 Million	74,258 New	74,258 $5.09 Million

276

42.5M

5.4K

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $891M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Krensavage Asset Management, LLC with notifications on news.